Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Onconetix (ONCO) EBT (2023 - 2025)

Onconetix (ONCO) has disclosed EBT for 2 consecutive years, with $28.6 million as the latest value for Q4 2024.

  • On a quarterly basis, EBT rose 229.86% to $28.6 million in Q4 2024 year-over-year; TTM through Dec 2024 was -$747894.0, a 97.98% increase, with the full-year FY2024 number at -$747894.0, up 97.98% from a year prior.
  • EBT was $28.6 million for Q4 2024 at Onconetix, up from -$3.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $28.6 million in Q4 2024 to a low of -$22.0 million in Q4 2023.